BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AE
3551
DELISTED
Adams Resources & Energy Inc
AE
| $4.21M | ﹤0.01% |
157,241
+73,488
| +88% | +$1.93M |
|
|
ICBK
3552
DELISTED
County Bancorp, Inc. Common Stock
ICBK
| $4.18M | ﹤0.01% |
199,861
+184,911
| +1,237% | +$3.77M |
|
3553
Pembina Pipeline
PBA
$28.1B
| $4.17M | ﹤0.01% |
166,879
+317
| +0.2% | +$7.33K |
|
3554
Eagle Bancorp Montana
EBMT
$188M
| $4.17M | ﹤0.01% |
239,759
+222,889
| +1,321% | +$3.8M |
|
3555
Champions Oncology
CSBR
$71.4M
| $4.17M | ﹤0.01% |
435,628
+287,677
| +194% | +$2.45M |
|
|
GOLD
3556
Gold.com Inc
GOLD
$1.25B
| $4.15M | ﹤0.01% |
435,976
+411,884
| +1,710% | +$3.25M |
|
|
CNTG
3557
DELISTED
Centogene N.V. Common Shares
CNTG
| $4.1M | ﹤0.01% |
179,187
+62,692
| +54% | +$1.18M |
|
3558
Northern Oil and Gas
NOG
$2.51B
| $4.08M | ﹤0.01% |
486,400
-1,600,870
| -77% | -$13.7M |
|
3559
Organogenesis Holdings
ORGO
$242M
| $4.08M | ﹤0.01% |
1,062,383
+411,298
| +63% | +$1.48M |
|
3560
Marker Therapeutics
MRKR
$19M
| $4.08M | ﹤0.01% |
197,031
+6,267
| +3% | +$137K |
|
3561
Peoples Bancorp of North Carolina
PEBK
$229M
| $4.07M | ﹤0.01% |
230,046
-18,580
| -7% | -$330K |
|
3562
SLR Investment Corp
SLRC
$698M
| $4.04M | ﹤0.01% |
252,672
+26,380
| +12% | +$401K |
|
3563
Rio Tinto
RIO
$167B
| $4.03M | ﹤0.01% |
71,777
-286,058
| -80% | -$14.5M |
|
3564
BlackRock Income Trust
BKT
$341M
| $4.02M | ﹤0.01% |
+217,373
| New | +$3.97M |
|
|
EVLO
3565
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $4.02M | ﹤0.01% |
41,051
+2,394
| +6% | +$210K |
|
|
BHR.PRB
3566
Braemar Hotels & Resorts 5.50% Series B Preferred Stock
BHR.PRB
$50.8M
| $4M | ﹤0.01% |
396,670
+3,330
| +0.8% | +$28.9K |
|
3567
Teck Resources
TECK
$33B
| $4M | ﹤0.01% |
383,737
-540,127
| -58% | -$4.96M |
|
|
MMAC
3568
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
| $4M | ﹤0.01% |
172,872
-41,408
| -19% | -$1.03M |
|
|
AZUL
3569
DELISTED
Azul
AZUL
| $3.98M | ﹤0.01% |
355,852
-5,585,584
| -94% | -$53.7M |
|
|
KLDO
3570
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $3.98M | ﹤0.01% |
534,940
-25,651
| -5% | -$172K |
|
3571
Climb Global Solutions
CLMB
$509M
| $3.97M | ﹤0.01% |
617,648
+11,068
| +2% | +$52.5K |
|
3572
Ryanair
RYAAY
$31B
| $3.95M | ﹤0.01% |
148,825
+27,755
| +23% | +$703K |
|
3573
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.59B
| $3.92M | ﹤0.01% |
+102,000
| New | +$3.73M |
|
3574
Culp Inc
CULP
$42.4M
| $3.91M | ﹤0.01% |
454,348
-386,769
| -46% | -$2.75M |
|
3575
Restaurant Brands International
QSR
$25.6B
| $3.9M | ﹤0.01% |
71,351
+7,975
| +13% | +$402K |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.